Chris E. Adkins
Impact in
Papers in
-
- Brain Metastases and Treatment 9
- Oncology 8
- Drug Transport and Resistance Mechanisms 5
- Cancer Treatment and Pharmacology 2
- Co-authors
- Paul R. Lockman (28 shared papers)Kaci A. Bohn (9 shared papers)Rajendar K. Mittapalli (10 shared papers)Afroz S. Mohammad (14 shared papers)Diane Palmieri (3 shared papers)Patricia S. Steeg (3 shared papers)Brunilde Gril (2 shared papers)Quentin R. Smith (2 shared papers)
- Journals
- Cancer Research (4 papers)Molecular Cancer Therapeutics (2 papers)Clinical Cancer Research (2 papers)Therapeutic Delivery (2 papers)Pharmaceutical Research (2 papers)
- Partner nations
- United StatesEgyptSweden
In The Last Decade
Chris E. Adkins
31 papers receiving 1.5k citations
Chris E. Adkins's Hit Papers
Peers
Comparison fields: 5 of 97
- Genetics 330
- Neurology 198
- Oncology 496
- Pulmonary and Respiratory Medicine 541
- Biomaterials 168
Countries citing papers authored by Chris E. Adkins
This map shows the geographic impact of Chris E. Adkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris E. Adkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris E. Adkins more than expected).
Fields of papers citing papers by Chris E. Adkins
This network shows the impact of papers produced by Chris E. Adkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris E. Adkins. The network helps show where Chris E. Adkins may publish in the future.
Co-authors
The 25 scholars most cited alongside Chris E. Adkins, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Heterogeneous Blood–Tumor Barrier Permeability Determines Drug Efficacy in Experimental Brain Metastases of Breast Cancer Hit paper breakdown → | 2010 | 532 |
| 2 | 2016 | 125 | |
| 3 | 2015 | 119 | |
| 4 | 2013 | 78 | |
| 5 | 2012 | 64 | |
| 6 | 2013 | 57 | |
| 7 | 2018 | 56 | |
| 8 | 2013 | 52 | |
| 9 | 2016 | 48 | |
| 10 | 2016 | 44 | |
| 11 | 2021 | 44 | |
| 12 | 2017 | 40 | |
| 13 | 2010 | 40 | |
| 14 | 2015 | 38 | |
| 15 | 2010 | 34 | |
| 16 | 2016 | 34 | |
| 17 | 2016 | 22 | |
| 18 | 2021 | 21 | |
| 19 | 2017 | 20 | |
| 20 | 2014 | 19 |
About Chris E. Adkins
Chris E. Adkins is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Neurology, Biomedical Engineering and Genetics, having authored 31 papers that have together received 1.5k indexed citations. Recurring topics across this work include Brain Metastases and Treatment (9 papers), Barrier Structure and Function Studies (7 papers), Nanoplatforms for cancer theranostics (6 papers), Drug Transport and Resistance Mechanisms (5 papers), Glioma Diagnosis and Treatment (5 papers), MRI in cancer diagnosis (2 papers), Cancer Treatment and Pharmacology (2 papers) and Angiogenesis and VEGF in Cancer (2 papers). The work is most often cited by research in Genetics (330 citations), Neurology (198 citations), Oncology (496 citations), Pulmonary and Respiratory Medicine (541 citations) and Biomaterials (168 citations). Chris E. Adkins has collaborated with scholars based in United States, Egypt and Sweden. Frequent co-authors include Paul R. Lockman, Kaci A. Bohn, Rajendar K. Mittapalli, Afroz S. Mohammad, Diane Palmieri, Patricia S. Steeg, Brunilde Gril, Quentin R. Smith, Werner J. Geldenhuys and Amanda Roberts. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, Clinical Cancer Research, Therapeutic Delivery and Pharmaceutical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.